Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 10, Issue -, Pages 3029-3037
Publisher
Dove Medical Press Ltd.
Online
2017-06-20
DOI
10.2147/ott.s114714

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.